| 29th Jul 2022 10:00 am |
RNS |
GSK Board change |
| 28th Jul 2022 1:01 pm |
RNS |
Director/PDMR Shareholding |
| 27th Jul 2022 7:00 am |
RNS |
2nd Quarter Results |
| 26th Jul 2022 5:35 pm |
RNS |
Holding(s) in Company |
| 22nd Jul 2022 4:45 pm |
RNS |
Holding(s) in Company |
| 22nd Jul 2022 4:17 pm |
RNS |
Board and Committee Changes |
| 19th Jul 2022 7:00 am |
RNS |
Completion of GSK Share Consolidation |
| 18th Jul 2022 6:00 pm |
RNS |
Holding(s) in Company |
| 18th Jul 2022 7:00 am |
RNS |
Haleon demerger completion and share consolidation |
| 12th Jul 2022 9:48 am |
RNS |
Director/PDMR Shareholding |
| 11th Jul 2022 5:30 pm |
RNS |
GSK |
| 8th Jul 2022 6:04 pm |
RNS |
Director/PDMR Shareholding |
| 8th Jul 2022 5:30 pm |
RNS |
Director/PDMR Shareholding |
| 8th Jul 2022 3:53 pm |
RNS |
Director/PDMR Shareholding |
| 8th Jul 2022 3:33 pm |
RNS |
Director/PDMR Shareholding |
| 8th Jul 2022 3:10 pm |
RNS |
Director/PDMR Shareholding |
| 6th Jul 2022 4:30 pm |
RNS |
Result of General Meeting |
| 6th Jul 2022 10:11 am |
RNS |
Director/PDMR Shareholding |
| 5th Jul 2022 12:43 pm |
RNS |
GSK disclose discontinued operations from Q2 2022 |
| 5th Jul 2022 9:45 am |
RNS |
Director/PDMR Shareholding |
| 5th Jul 2022 9:30 am |
RNS |
Director/PDMR Shareholding |
| 1st Jul 2022 3:27 pm |
RNS |
Total Voting Rights |
| 1st Jul 2022 2:45 pm |
RNS |
GSK completes acquisition of Sierra Oncology |
| 28th Jun 2022 5:56 pm |
RNS |
Director/PDMR Shareholding |
| 28th Jun 2022 7:00 am |
RNS |
GSK files Shingrix 18+ at risk indication in Japan |
| 27th Jun 2022 4:08 pm |
RNS |
Director/PDMR Shareholding |
| 24th Jun 2022 3:44 pm |
RNS |
Director/PDMR Shareholding |
| 16th Jun 2022 10:58 am |
RNS |
Director/PDMR Shareholding |
| 10th Jun 2022 7:00 am |
RNS |
Positive phase III data for GSK’s RSV OA vaccine |
| 9th Jun 2022 4:28 pm |
RNS |
Director/PDMR Shareholding |
| 7th Jun 2022 5:17 pm |
RNS |
Director/PDMR Shareholding |
| 7th Jun 2022 12:00 pm |
EQS |
Hardman & Co Life Sciences Research: Long-term pharmaceutical industry cost and EBIT analysis |
| 6th Jun 2022 7:00 am |
RNS |
US FDA approval of Priorix |
| 1st Jun 2022 4:55 pm |
RNS |
Total Voting Rights |
| 1st Jun 2022 1:00 pm |
RNS |
Demerger update: Publication of Documents |
| 1st Jun 2022 7:00 am |
RNS |
Demerger update: Submission of Documents to FCA |
| 31st May 2022 7:00 am |
RNS |
GSK to acquire Affinivax, Inc. |
| 30th May 2022 10:00 am |
RNS |
Further appointments to Designate Haleon Board |
| 27th May 2022 7:00 am |
RNS |
GSK Cervarix two-dose schedule approved by NMPA |
| 25th May 2022 3:41 pm |
PRN |
Director/PDMR Shareholding |
